Professor of Medicine (Medical Oncology); Associate Director for Clinical Sciences, Yale Cancer Center; Clinical Program Leader, Gastrointestinal Cancers Program, Smilow Cancer Hospital; Clinical Research Program Leader, Gastrointestinal Cancers Program, Yale Cancer Center
Medical Oncology, Gastrointestinal Cancer Program, Cancer Center, Yale
gastrointestinal cancer; colon cancer; pancreatic cancer; gastric cancer; biliary cancer
|
Cancers Treated:
Colon (including Rectum),
Gastrointestinal (including Stomach),
Pancreas Accepts New Patients? Yes Patient Type: Adult Accepts appointments from patients or physicians |
|
19F-MRS (Magnetic Resonance Spectroscopy) Studies of in-vivo 5-Fluorouracil Pharmacokinetics with and without Bevacizumab in Patients with Liver Metastases from Adenocarcinoma of the colon
Disease/Condition: Colon Cancer |
|
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Disease/Condition: Colorectal Cancer |
|
Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients with Advanced Breast and Gastrointestinal Tumors
Disease/Condition: Gastrointestinal Tumors; Metastatic Breast Cancer |
Appointment Phone
(203) 200-4422
Appointment Fax
(203) 200-6950
howard.hochster@yale.edu
Yale Gastrointestinal Cancers Program
Smilow Cancer Hospital at Yale - New Haven
South Frontage Road and Park Street
8th Floor Multispecialty Care Center
New Haven, CT 06510